Dr. Robert Whitfield reports that 29% of explant capsule specimens showed PCR contamination, revealing cellular-level pathology in breast implant illness. The Sharp Method focuses on systemic preparation and recovery, not just implant removal. He's hosting a free webinar with Dr. Fab Mancini to explain the science.
When we talk about BII, we don't rely on anecdotes, we rely on data. In our analysis of explant cases, we found 29% PCR contamination rate in the capsule specimens. This isn't a guess, it's a measurable metric. Understanding what is happening at the cellular level is critical to developing an effective recovery protocol. This is why the Sharp Method focuses on systemic preparation and recovery, not just the surgical removal. This Thursday, Dr. Fab Mancini and I are hosting a free webinar breaking down the science of BII and explant recovery. Link in the bio to register. We don't rely on anecdotes, we rely on our data. Our analysis shows once again that 29% on, uh, PCR analysis have a contaminant. Understanding the science is critical to recovery. Join Dr. Fab Mancini and me this Thursday for a free webinar on BI and the Sharp Method. Link in the bio.
